Risk of Cutaneous and Genital Warts in Organ and Hematopoietic Stem Cell Transplant Patients: A Nationwide Population-Based Study

器官移植和造血干细胞移植患者发生皮肤疣和生殖器疣的风险:一项全国性人群研究

阅读:3

Abstract

BACKGROUND: Solid organ transplantation and hematopoietic stem cell transplantation are known risk factors for viral warts. However, large-scale studies on the association between transplantation and the risk of cutaneous and genital warts are limited. This study aimed to evaluate the relationship between transplantation and the risk of developing cutaneous and genital warts using a nationwide claims database. METHODS: We conducted a retrospective cohort study using the Korean National Health Insurance Claims Database. The incidence of cutaneous and genital warts in transplant recipients was compared to that in the control population using multivariable Cox proportional hazard regression analysis. The adjusted hazard ratio (aHR) and 95% confidence interval (CI) were calculated to assess the risk. RESULTS: Transplant recipients exhibited a significantly increased risk of cutaneous warts (aHR, 3.73; 95% CI, 3.49-3.98) and genital warts (aHR, 1.18; 95% CI, 1.07-1.29) compared to controls. The risk of cutaneous warts was elevated across all age groups, with the highest risk observed in individuals aged 20-39 years (aHR, 4.52; 95% CI, 3.92-5.22) and 40-59 years (aHR, 4.56; 95% CI, 4.14-5.02). In contrast, the risk of genital warts was highest in patients aged ≥ 60 years (aHR, 2.09; 95% CI, 1.47-2.99). CONCLUSION: This study demonstrates that transplantation is associated with an increased risk of both cutaneous and genital warts, with variations in risk based on age. These findings highlight the need for targeted surveillance and management strategies for wart prevention in transplant recipients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。